NSN 6505-01-692-5287 · NIIN 016925287 · FSC 6505
NO DASHES 6505016925287
In Stock
CORONAVIRUS VACCINE
Drugs and Biologicals
Technical characteristics
7 rows
Straight from the federal item record. Entries the record leaves empty are shown empty — nothing is filled in on its behalf.
| MRC | Requirement | Value |
|---|---|---|
| CSGS | ADMINISTRATION | INJECTION |
| CMDM | VIRUS STRAIN | COVID-19 |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | MILLILITERS 5.0 |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | ADULT MODERNA COVID-19 VACCINE, VIAL 10S |
| CQCT | PRIMARY CONTAINER TYPE | VIAL, GLASS |
| FEAT | SPECIAL FEATURES | SUSPENSION FOR INTRAMUSCULAR INJECTION; 10 MULTIPLE-DOSE VIALS; EACH VIAL CONTAINS 10 TO 11 DOSES (0.5 ML EACH); EACH 0.5 ML DOSE OF THE MODERNA COVID-19 VACCINE CONTAINS 100 MCG OF A NUCLEOSIDE-MODIFIED MESSENGER RNA ENCODING THE VIRAL SPIKE (S) GLYCOPROTEIN OF SARS-COV-2. EACH DOSE OF THE MODERNA COVID-19 VACCINE ALSO INCLUDES THE FOLLOWING INGREDIENTS: LIPIDS (SM-102; 1,2-DIMYRISTOYL-RAC-GLYCERO-3-METHOXYPOLYETHYLENE GLYCOL-2000 (PEG2000-DMG);CHOLESTEROL; AND 1,2-DISTEAROYL-SN-GLYCERO-3-PHOSPHOCHOLINE (DSPC), TROMETHAMINE. TROMETHAMINE HYDROCHLORIDE, ACETIC ACID, SODIUM ACETATE, AND SUCROSE. STORE FROZEN/BETWEEN -50 TO -15 DEGREES C (-58 TO 5 DEGREES F) UNTIL READY FOR USE; PROTECT FROM LIGHT; NO PRESERVATIVES; AFTER FIRST USE, HOLD AT 2 TO 25 DEGREES C (36 TO 77 DEGREES F), DISCARD AFTER 12 HOURS; DO NOT REFREEZE ONCE THAWED; FOR USE UNDER EMERGENCY USE AUTHOIZATION. |